ID   TT2609-B02
AC   CVCL_A595
DR   Wikidata; Q54973223
RX   PubMed=11716037;
CC   Population: Caucasian.
CC   Doubling time: 23 hours (PubMed=11716037).
CC   Karyotypic information: Near diploid karyotype (PubMed=11716037).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A594 ! TT2609-A02
OI   CVCL_2218 ! TT2609-C02
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=11716037; DOI=10.1089/105072501753210966;
RA   Geldof A.A., Versteegh R.T., van Mourik J.C., Rooimans M.A.,
RA   Arwert F., Hermsen M.A.J.A., Schadee-Eestermans I.L.,
RA   van Dongen G.A.M.S., van der Valk P., van der Poest Clement E.H.,
RA   Lips P., Teule G.J.J.;
RT   "Clonally related but phenotypically divergent human cancer cell lines
RT   derived from a single follicular thyroid cancer recurrence (TT2609).";
RL   Thyroid 11:909-917(2001).
//